Showing results (1951-1960 of 2,750) with videos related to

Sort By:
Pageof 275
Clinical and Experimental Nephrology|March 10, 2015
Benefits of a 12-week lifestyle modification program including diet and combined aerobic and resistance exercise on albuminuria in diabetic and non-diabetic Japanese populationsKeiko Yamamoto-Kabasawa, Michihiro Hosojima, Yusuke Yata, et al.
Clinical and Experimental Nephrology|March 12, 2015
Cardiac valve calcification is associated with presence and severity of coronary artery disease in patients with pre-dialysis chronic kidney diseaseIl Young Kim, Min Jung Kim, Dong Won Lee, et al.
Clinical and Experimental Nephrology|March 22, 2015
Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trialSawako Kato, Shoichi Maruyama, Hirofumi Makino, et al.
Clinical and Experimental Nephrology|July 5, 2020
Influence of muscle mass on the estimation of glomerular filtration rate in Japanese terminal cancer patientsYoshihiro Uekuzu, Takashi Higashiguchi, Akihiko Futamura, et al.
Clinical and Experimental Nephrology|June 29, 2020
Estimated plasma osmolarity and risk of end-stage kidney disease in patients with IgA nephropathyShigeru Tanaka, Toshiaki Nakano, Masanori Tokumoto, et al.
Clinical and Experimental Nephrology|June 26, 2020
The need for disruptive innovation in acute kidney injuryKent Doi
Clinical and Experimental Nephrology|July 27, 2012
Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidismYuki Tsuruta, Kazuhiro Okano, Kan Kikuchi, et al.
Clinical and Experimental Nephrology|July 21, 2012
Reduction in augmentation index after successful renal transplantationManpreet Kaur, Charanjit Lal, Dipankar Bhowmik, et al.
Clinical and Experimental Nephrology|January 30, 2015
Comparative effects of mesenchymal stem cell therapy in distinct stages of chronic renal failureHeloisa Cristina Caldas, Thaís Amarante Peres de Paula Couto, Ida Maria Maximina Fernandes, et al.
Clinical and Experimental Nephrology|June 21, 2012
Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signalingJi-Young Choi, Tae-Sun Ha, Hye-Young Park, et al.
Pageof 275